Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer.

MLA

Zhou, Zhen Ni, et al. “Adoption of Minimally Invasive Surgery after Neoadjuvant Chemotherapy in Women with Metastatic Uterine Cancer.” Gynecologic Oncology, vol. 164, no. 2, Feb. 2022, pp. 341–47. EBSCOhost, https://doi.org/10.1016/j.ygyno.2021.12.005.

APA

Zhou, Z. N., Chen, L., Melamed, A., St Clair, C. M., Hou, J. Y., Khoury-Collado, F., Gockley, A., Hershman, D. L., & Wright, J. D. (2022). Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer. Gynecologic Oncology, 164(2), 341–347. https://doi.org/10.1016/j.ygyno.2021.12.005

Chicago

Zhou, Zhen Ni, Ling Chen, Alexander Melamed, Caryn M St Clair, June Y Hou, Fady Khoury-Collado, Allison Gockley, Dawn L Hershman, and Jason D Wright. 2022. “Adoption of Minimally Invasive Surgery after Neoadjuvant Chemotherapy in Women with Metastatic Uterine Cancer.” Gynecologic Oncology 164 (2): 341–47. doi:10.1016/j.ygyno.2021.12.005.